Trimi vs Hims vs Ro: Comparing GLP-1 Weight Loss Programs

    By Trimi Medical Team12 min read

    If you are considering a telehealth weight loss program with GLP-1 medications, you have likely come across Trimi, Hims (Hims & Hers), and Ro as popular options. All three offer access to GLP-1 medications through telehealth consultations, but they differ meaningfully in medications offered, pricing models, clinical support depth, and overall approach. This comparison is written by the Trimi team, so we want to be upfront about that bias, but we will be as honest and transparent as possible, including acknowledging where competitors have genuine strengths.

    Transparency Note: This comparison is published by Trimi. While we strive for accuracy and fairness, we have an inherent interest in the outcome. We encourage you to verify all competitor information directly on their websites, as offerings and pricing change frequently. Last verified: April 2026.

    Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication.

    Quick Comparison Overview

    FeatureTrimiHims & HersRo
    GLP-1 medicationsCompounded semaglutide, compounded tirzepatideCompounded semaglutide (compounded GLP-1/B12)Compounded semaglutide, brand-name options (varies)
    Consultation typeTelehealth with dedicated providerAsynchronous + telehealthAsynchronous + telehealth
    Starting priceCheck trytrimi.com for current pricingStarting ~$199/monthStarting ~$145-399/month (varies by medication)
    Medication included in priceYesYesYes (varies by plan)
    Provider follow-upsIncluded, ongoingIncludedIncluded
    Pharmacy type503A community sterile-compounding pharmacy503A community sterile-compounding pharmacy503A community sterile-compounding pharmacy / retail

    Note: Pricing and offerings change frequently. Visit each company's website for the most current information.

    Medications Offered

    Trimi

    Trimi focuses on compounded semaglutide and compounded tirzepatide, providing access to both major GLP-1 medications at doses customized by the prescribing provider. The compounded medications are sourced from FDA-registered 503A outsourcing facilities. Having both semaglutide and tirzepatide available means providers can match patients to the most appropriate medication based on their health profile, weight loss goals, and response patterns.

    Hims & Hers

    Hims has offered compounded GLP-1 formulations, including semaglutide combined with B12 (vitamin supplementation). Hims operates at very large scale as a publicly traded company with multiple product lines beyond weight loss (hair loss, ED, skincare, mental health). This scale brings strong brand recognition and infrastructure but may mean less specialization in weight management specifically.

    Where Hims excels: Brand recognition, established infrastructure, and a broad ecosystem of health products. If you already use Hims for other health needs, the consolidated platform may be convenient.

    Ro

    Ro (previously Ro Health) offers GLP-1 medications through its weight loss program, which has historically included both compounded and brand-name options depending on availability and patient eligibility. Ro also operates at significant scale with a well-developed technology platform. Their Body Program includes metabolic testing and clinical support.

    Where Ro excels: Well-developed technology platform, metabolic lab testing integration, and a comprehensive body program approach that extends beyond medication alone.

    Clinical Support and Provider Access

    This is where programs diverge most meaningfully, and where we believe Trimi's approach stands out:

    Trimi's Approach

    Trimi was built specifically around GLP-1 weight loss treatment. Our clinical model emphasizes:

    • Dedicated providers: Clinicians who specialize in GLP-1 therapy and obesity medicine, not generalists rotating through multiple product lines.
    • Ongoing support: Regular check-ins, dose adjustments, and lifestyle guidance as part of the standard program, not add-on services.
    • Responsive communication: Access to your clinical team for questions about side effects, diet, dose timing, and other concerns.
    • Personalized titration: Dosing plans tailored to individual tolerance and response rather than rigid protocols.

    Hims and Ro Approach

    Both Hims and Ro offer provider consultations as part of their programs. A common model for large-scale telehealth platforms involves asynchronous intake (you fill out a questionnaire), provider review and prescription, and periodic check-ins. This model is efficient and works well for many patients, particularly those who are self-directed and comfortable managing their own care with less frequent touchpoints.

    Honest assessment: Both Hims and Ro have invested significantly in clinical quality and patient experience. The level of support you receive depends partly on the specific provider assigned to you and partly on how proactively you engage with the program. Some patients have excellent experiences with all three platforms; others feel they need more support than a large-scale model provides.

    Pricing and Value

    Price comparison in this space is genuinely difficult because programs bundle differently:

    • Some include medication in the monthly subscription; others charge separately
    • Dose-dependent pricing means cost increases as you titrate up
    • Promotional pricing may not reflect long-term costs
    • Insurance involvement (for brand-name options at Ro) adds another variable

    Our honest recommendation: When comparing prices, calculate the total monthly cost at your expected maintenance dose including all fees (consultation, medication, shipping). Ask about price changes with dose increases. And consider the value of clinical support, as the cheapest program is not the best value if you need more guidance than it provides.

    Program Philosophy Differences

    Trimi: Specialized Weight Loss Focus

    Trimi is built exclusively for GLP-1 weight management. Every aspect of the program, from provider training to patient communication to content and education, is designed around helping patients succeed with GLP-1 therapy specifically. This specialization means deeper expertise in the niche but a narrower product offering.

    Hims: Consumer Health Ecosystem

    Hims approaches weight loss as one of many consumer health categories. Their strength is in brand building, consumer experience, and platform scale. Weight loss is integrated into a broader health and wellness ecosystem that includes multiple condition areas. This can be advantageous for patients who want a single platform for multiple health needs.

    Ro: Technology-Forward Health Platform

    Ro emphasizes technology integration and data-driven care. Their Body Program includes features like at-home metabolic testing and structured milestone tracking. This appeals to patients who want quantified progress and a more data-oriented approach to their weight loss journey.

    Who Each Program Is Best For

    Choose Trimi If:

    • You want a program built specifically around GLP-1 weight loss
    • Dedicated provider relationships and personalized clinical support matter to you
    • You want access to both semaglutide and tirzepatide options
    • You value a smaller, more focused program over a large-scale platform

    Choose Hims If:

    • You value strong brand recognition and established infrastructure
    • You already use Hims for other health products and want a consolidated platform
    • You prefer a consumer-grade digital experience with polished design and ease of use
    • You are comfortable with a more self-directed approach to your treatment

    Choose Ro If:

    • You want a technology-forward, data-driven approach
    • Features like metabolic testing and quantified tracking appeal to you
    • You want the option of brand-name medications alongside compounded options
    • You value a comprehensive "body program" that extends beyond just medication

    Important Factors Beyond the Platform

    Regardless of which platform you choose, several factors matter more than the company name on the box:

    • Medication quality: Ensure the pharmacy is an FDA-registered 503A community sterile-compounding pharmacy with documented quality controls. All three platforms listed here use 503A community sterile-compounding pharmacy.
    • Provider qualifications: Your prescribing provider should be licensed in your state and experienced with GLP-1 medications for weight loss.
    • Realistic expectations: No program guarantees specific results. Average weight loss with GLP-1 medications is 15-22% over 12-18 months, but individual results vary widely.
    • Long-term planning: Ask about maintenance strategies, dose reduction options, and what happens if you want to stop treatment. A good program plans for the long term, not just the first few months.
    • Lifestyle support: Medication alone is not enough. The best programs integrate dietary guidance, exercise recommendations, and behavioral support.

    What We Admire About Our Competitors

    In the interest of transparency, here is what we genuinely respect about Hims and Ro:

    • Hims: They have done an extraordinary job normalizing conversations about health conditions that were previously stigmatized. Their consumer marketing and product design are best-in-class, and they have made healthcare feel more accessible and less clinical for millions of people.
    • Ro: Their investment in clinical technology and at-home diagnostics is innovative. The integration of lab testing into a telehealth weight loss program represents a meaningful advancement in remote care capabilities. Their focus on measuring and tracking outcomes is commendable.

    Competition in this space ultimately benefits patients by driving innovation, improving quality, and applying downward pressure on pricing. We welcome it.

    Getting Started

    If you are ready to explore GLP-1 weight loss treatment, we encourage you to evaluate all your options. Compare pricing at your expected dose, ask about clinical support models, and choose the program that best matches your needs and preferences.

    To learn more about Trimi specifically, visit our how it works page or browse our treatment options. Our team is happy to answer questions, even if you ultimately choose a different provider.

    Frequently Asked Questions

    Is Trimi better than Hims for weight loss?

    "Better" depends on what you value. Trimi offers more specialized GLP-1 expertise and personalized provider support. Hims offers a broader health ecosystem, strong brand recognition, and polished consumer experience. Both provide access to compounded GLP-1 medications through 503A community sterile-compounding pharmacy. Consider which approach aligns better with how you want to manage your care.

    Which is cheaper: Trimi, Hims, or Ro?

    Pricing varies by medication, dose, and plan structure, and all three companies update their pricing periodically. Calculate total monthly cost at your expected maintenance dose, including all fees. The cheapest option is not necessarily the best value if it provides less clinical support than you need. Visit each company's website for current pricing.

    Do Trimi, Hims, and Ro offer the same medications?

    All three offer compounded semaglutide. Trimi also offers compounded tirzepatide. Ro has historically offered pathways to brand-name medications (Wegovy, Ozempic) depending on insurance coverage. Medication availability varies by platform, state, and individual eligibility. Confirm specific medication availability directly with each provider.

    Are online GLP-1 programs legitimate?

    Legitimate telehealth GLP-1 programs involve licensed healthcare providers prescribing FDA-registered medications, which is legal and increasingly common. Look for: licensed prescribers in your state, medications from 503A community sterile-compounding pharmacy, transparent pricing, and ongoing clinical follow-up. Avoid programs that offer medication without a provider consultation or that do not require a prescription.

    Can I switch from Hims or Ro to Trimi?

    Yes. Switching between telehealth weight loss programs is straightforward. A Trimi provider will evaluate your history, current dose, and response, then continue your treatment plan or adjust as needed. There is no medical reason you cannot transfer care between qualified providers.

    What should I look for in a GLP-1 weight loss program?

    Key factors: (1) medication quality from FDA-registered pharmacies, (2) licensed, experienced providers, (3) transparent pricing without hidden fees, (4) ongoing clinical support and dose adjustment, (5) lifestyle guidance beyond just medication, and (6) a long-term maintenance plan. Any program that treats GLP-1 therapy as a quick fix rather than a long-term health strategy should be approached with caution.

    Sources & References

    1. STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
    2. SURMOUNT-1 trial: tirzepatide for obesity (PubMed).
    3. SELECT trial: semaglutide and cardiovascular outcomes in obesity without diabetes (PubMed).
    4. Wegovy prescribing information from the FDA. and Zepbound prescribing information from the FDA.

    Related Reading

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: May 19, 2026

    TMT

    Written by Trimi Medical Team

    Our team of healthcare professionals specializes in weight management and metabolic health, providing evidence-based information to help you make informed decisions about your health journey.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook
    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Clinician-reviewed guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares.

    Four-way comparison of the most prescribed weight loss medications in 2026. Compare efficacy, side effects, cost, duration of use, and who each drug is best for.

    Compare semaglutide, tirzepatide, and other GLP-1 medications for weight loss. Updated 2025 rankings based on clinical data, cost, and real-world results.

    Hims tirzepatide review for 2026. Compare Hims' compounded tirzepatide pricing, results, and patient experience to Trimi's $125/mo tirzepatide program.

    Start your GLP-1 journey — from $99/mo

    Get Started